| Metric | Q2 2020 | Q1 2020 | Q2 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $216M | $308M | $216M | -29.7% | 0.2% |
| Op. Income | $33M | $70M | $47M | -53.0% | -30.3% |
| Gross Margin | 32.4% | 33.8% | 36.4% | -1.4pp | -4.0pp |
| Net Margin | 5.3% | 2.6% | 11.6% | 2.7pp | -6.3pp |
| EPS (Diluted) | $0.50 | $0.33 | $0.96 | 51.5% | -47.9% |
| Free Cash Flow | $31M | $15M | $16M | 98.0% | 89.2% |
| Item | Amount |
|---|---|
| REVENUE | $216M |
| Cost of Revenue | $146M |
| GROSS PROFIT | $70M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $24M |
| SG&A Expenses | $24M |
| Other Expenses | $13M |
| Operating Expenses | $37M |
| Cost & Expenses | $183M |
| OPERATING INCOME | $33M |
| Interest Income | $49.0K |
| Interest Expense | $15M |
| Other Income/Expenses | -$16M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $11M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $11M |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $12M |
| EBIT | $32M |
| EBITDA | $45M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $216M |
| Cost of Revenue | $146M |
| GROSS PROFIT | $70M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $24M |
| SG&A Expenses | $24M |
| Other Expenses | $13M |
| Operating Expenses | $37M |
| Cost & Expenses | $183M |
| OPERATING INCOME | $33M |
| Interest Income | $49.0K |
| Interest Expense | $15M |
| Other Income/Expenses | -$16M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $5M |
| Net Income from Continuing Ops | $11M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $11M |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $12M |
| EBIT | $32M |
| EBITDA | $45M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $11M |
| Depreciation & Amortization | $14M |
| Stock-Based Compensation | $3M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $35M |
| Change in Working Capital | -$27M |
| OPERATING CASH FLOW | $36M |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $3M |
| NET CASH FROM INVESTING | -$3M |
| Net Debt Issuance | -$7M |
| Common Stock Repurchased | -$1M |
| Common Dividends Paid | -$9M |
| Other Financing Activities | $115M |
| NET CASH FROM FINANCING | $97M |
| FREE CASH FLOW | $31M |
| Net Change in Cash | $131M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $132M |
| Short-Term Investments | $0 |
| Net Receivables | $66M |
| Inventory | $2M |
| Other Current Assets | $47M |
| TOTAL CURRENT ASSETS | $266M |
| PP&E (Net) | $1.3B |
| Goodwill | $47M |
| Intangible Assets | $294.0K |
| Long-Term Investments | $0 |
| Tax Assets | $77M |
| Other Non-Current Assets | $211M |
| TOTAL NON-CURRENT ASSETS | $1.6B |
| TOTAL ASSETS | $1.9B |
| Account Payables | $48M |
| Short-Term Debt | $14M |
| Deferred Revenue | $5M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $346M |
| Long-Term Debt | $1.4B |
| Deferred Revenue NC | $40M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $203M |
| TOTAL NON-CURRENT LIABILITIES | $2.4B |
| TOTAL LIABILITIES | $2.7B |
| Common Stock | $823.0K |
| Additional Paid-In Capital | $490M |
| Retained Earnings | $1.6B |
| Treasury Stock | -$2.8B |
| Accum. Other Comp. Income | -$133M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$877M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$877M |
| TOTAL LIABILITIES & EQUITY | $1.9B |
| Total Debt | $2.3B |
| Net Debt | $2.2B |
